Ifp Advisors, Inc Axonics, Inc. Transaction History

Ifp Advisors, Inc

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$59.56 - $76.6 $1,548 - $1,991	-26 Reduced 52.0%	24 $1,000
Q3 2022 Nov 08, 2022	BUY	$57.96 - $78.12 $1,506 - $2,031	26 Added 108.33%	50 $2,000
Q2 2022 Sep 06, 2022	BUY	$39.5 - $64.42 $948 - $1,546	24 New	24 $1,000
Q2 2022 Aug 12, 2022	SELL	$39.5 - $64.42 $948 - $1,546	-24 Closed	0 $0
Q1 2022 Aug 08, 2022	BUY	$43.74 - $62.76 $1,049 - $1,506	24 New	24 $1,000
Q3 2021 Oct 06, 2021	SELL	$59.21 - $78.66 $0 - $0	0 Closed	0 $0
Q2 2021 Jul 13, 2021	BUY	$51.39 - $66.9 $0 - $0	0 New	0 $0
Q1 2021 Apr 30, 2021	BUY	$49.14 - $59.89 $0 - $0	0 New	0 $0
Q4 2020 Jan 25, 2021	BUY	$42.19 - $51.5 $0 - $0	0 New	0 $0
Q3 2020 Oct 29, 2020	SELL	$35.33 - $51.04 $12,577 - $18,170	-356 Closed	0 $0
Q3 2019 Nov 07, 2019	BUY	$26.92 - $42.41 $9,583 - $15,097	356 New	356 $10,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.